Marked Lability in Urinary Cortisol Levels in Subgroups of Combat Veterans With Posttraumatic Stress Disorder During an Intensive Exposure Treatment Program

Objective The objective of this study was to obtain longitudinal data on lability of cortisol levels in posttraumatic stress disorder (PTSD) because previous studies have largely been based on sampling at a single time point and have yielded varying results. Methods This study measured urinary cortisol levels at admission, midcourse, and discharge during a 90-day hospitalization period in male Vietnam combat veterans with PTSD (N = 51). Results Although there were no significant differences in the mean ± SEM urinary cortisol levels between the admission (59.4 ± 3.0 &mgr;g/d), midcourse (55.6 ± 3.9 &mgr;g/d), and discharge (53.4 ± 3.4 &mgr;g/d) values, marked lability of cortisol levels in individual patients was observed over time, with changes ranging from + 93 to −58 &mgr;g/d from admission to midcourse. In addition, this hormonal lability defined discrete subgroups of patients on the basis of the longitudinal pattern of cortisol change during exposure treatment, and there were significant psychometric differences in the level of social functioning between these subgroups. Conclusions The findings do not support the concept of either a static “hypocortisolism” or “hypercortisolism” in PTSD, but rather suggest a psychogenic basis for cortisol alterations in PTSD in relation to psychosocial stress and indicate a central regulatory dysfunction of the hypothalamic-pituitary-adrenal axis characterized by a dynamic tendency to overreact in both upward and downward directions. The longitudinal findings fit with recent observations that cortisol elevations occur when acutely superimposed stressful conditions emotionally engage patients and overwhelm the usually dominating disengaging coping mechanisms associated with suppression of cortisol levels in PTSD. The findings emphasize the importance of longitudinal data in studies of the hypothalamic-pituitary-adrenal axis in PTSD.

[1]  M. T. Singer.  Presidential address. Engagement-involvement: a central phenomenon in psychophysiological research. , 1974, Psychosomatic medicine.

[2]  J. Mason,et al.  CORTICOSTEROID RESPONSES TO HOSPITAL ADMISSION. , 1965, Archives of general psychiatry.

[3]  W. Bunney,et al.  STUDY OF A PATIENT WITH 48-HOUR MANIC-DEPRESSIVE CYCLES. II. STRONG POSITIVE CORRELATION BETWEEN ENDOCRINE FACTORS AND MANIC DEFENSE PATTERNS. , 1965, Archives of general psychiatry.

[4]  J. P. Wilson,et al.  Stages of decompensation in combat-related posttraumatic stress disorder: A new conceptual model , 1996, Integrative physiological and behavioral science : the official journal of the Pavlovian Society.

[5]  O. D. Leon.  Neurobiological and clinical consequences of stress , 1997 .

[6]  Larry J. Siever,et al.  Cortisol regulation in posttraumatic stress disorder and major depression: A chronobiological analysis , 1996, Biological Psychiatry.

[7]  J. Mason,et al.  Corticosteroid Excretion in Normal Young Adults Living Under “Basal” Conditions , 1965, Psychosomatic medicine.

[8]  S. B. Friedman,et al.  RELATIONSHIP BETWEEN PSYCHOLOGICAL DEFENSES AND MEAN URINARY 17-HYDROXYCORTICOSTEROID EXCRETION RATES. I. A PREDICTIVE STUDY OF PARENTS OF FATALLY ILL CHILDREN. , 1964, Psychosomatic medicine.

[9]  J. Mason,et al.  Preoperative emotional states and adrenal cortical activity; studies on cardiac and pulmonary surgery patients. , 1957, A.M.A. archives of neurology and psychiatry.

[10]  S. Southwick,et al.  Psychogenic Lowering of Urinary Cortisol Levels Linked to Increased Emotional Numbing and a Shame-Depressive Syndrome in Combat-Related Posttraumatic Stress Disorder , 2001, Psychosomatic medicine.

[11]  E. Bernstein,et al.  Development, reliability, and validity of a dissociation scale. , 1986, The Journal of nervous and mental disease.

[12]  Dennis S. Charney,et al.  A CLINICIAN RATING SCALE FOR ASSESSING CURRENT AND LIFETIME PTSD: THE CAPS-1 , 1990 .

[13]  A. Baum,et al.  Urinary Catecholamines and Cortisol in Recent-Onset Posttraumatic Stress Disorder After Motor Vehicle Accidents , 2000, Psychosomatic medicine.

[14]  Kathryn L. Taylor,et al.  Clinical evaluation of a measure to assess combat exposure. , 1989 .

[15]  S. Southwick,et al.  Low Urinary Cortisol Excretion in Patients with Posttraumatic Stress Disorder , 1990, The Journal of nervous and mental disease.

[16]  J W Mason,et al.  Urinary Free-Cortisol Levels in Posttraumatic Stress Disorder Patients , 1986, The Journal of nervous and mental disease.

[17]  J. Mason,et al.  Psychoendocrine Aspects of Acute Schizophrenic Reactions , 1963, Psychosomatic medicine.

[18]  E. Giller,et al.  The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder , 1990, Biological Psychiatry.

[19]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[20]  T. Keane,et al.  Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: three studies in reliability and validity. , 1988, Journal of consulting and clinical psychology.